Development of clinical risk-prediction models for uterine atony following vaginal and cesarean delivery
- PMID: 35550835
- DOI: 10.1016/j.ijoa.2022.103550
Development of clinical risk-prediction models for uterine atony following vaginal and cesarean delivery
Abstract
Background: Uterine atony is the most common cause of postpartum hemorrhage and is associated with substantial morbidity. Prospectively identifying women at increased risk of atony may reduce the incidence of subsequent adverse events. We sought to develop and evaluate clinical risk-prediction models for uterine atony following vaginal and cesarean delivery, using prespecified risk factors identified from systematic review.
Methods: Using retrospective data from vaginal and cesarean deliveries occurring at a single institution between 2010 and 2019, antepartum and intrapartum risk-prediction models for uterine atony, defined by supplementary uterotonic administration in addition to prophylactic oxytocin infusion, were developed using logistic regression. The C-statistic quantified the ability of the model to discriminate between cases and controls.
Results: Data were available for 4773 atony cases and 23 933 controls. The antepartum model included 20 risk factors and exhibited moderate discriminatory ability (C-statistic 0.61, 95% confidence interval 0.60 to 0.62). The intrapartum model included 27 risk factors and showed improved discriminatory ability (C-statistic 0.68, 95% confidence interval 0.67 to 0.69).
Conclusions: We identified antepartum and intrapartum risk-prediction models to quantify patients' risk of uterine atony. Models performed similarly for all delivery modes, races, and ethnic groups. Future work should further improve these models through inclusion of more comprehensive prediction data.
Keywords: Logistic regression; Maternal morbidity; Postpartum hemorrhage; Risk prediction; Uterine atony.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.BMC Pregnancy Childbirth. 2017 Nov 29;17(1):399. doi: 10.1186/s12884-017-1584-1. BMC Pregnancy Childbirth. 2017. PMID: 29187156 Free PMC article.
-
Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.Arch Gynecol Obstet. 2009 Nov;280(5):707-12. doi: 10.1007/s00404-009-0973-8. Epub 2009 Feb 20. Arch Gynecol Obstet. 2009. PMID: 19229549 Clinical Trial.
-
The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.Anesth Analg. 2015 Jul;121(1):159-164. doi: 10.1213/ANE.0000000000000781. Anesth Analg. 2015. PMID: 25902327 Clinical Trial.
-
Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.Am J Obstet Gynecol. 2013 Jul;209(1):51.e1-6. doi: 10.1016/j.ajog.2013.03.011. Epub 2013 Mar 15. Am J Obstet Gynecol. 2013. PMID: 23507549 Free PMC article. Clinical Trial.
-
Uterine atony.Curr Opin Obstet Gynecol. 2022 Apr 1;34(2):82-89. doi: 10.1097/GCO.0000000000000776. Curr Opin Obstet Gynecol. 2022. PMID: 35102109 Review.
Cited by
-
Zero-shot interpretable phenotyping of postpartum hemorrhage using large language models.NPJ Digit Med. 2023 Nov 30;6(1):212. doi: 10.1038/s41746-023-00957-x. NPJ Digit Med. 2023. PMID: 38036723 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources